Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Income from Continuing Operations of 37000000.0 for Q1 2026, down 123.42% year-over-year from 158000000.0 in Q1 2025, and down 109.69% quarter-over-quarter from 382000000.0 in Q4 2025.
Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Income from Continuing Operations for 18 consecutive years, with 37000000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 123.42% year-over-year to 37000000.0; the TTM figure through Mar 2026 stood at 1412000000.0 (up 4.75% YoY), while the FY2025 annual figure was 1678000000.0, down 1.58% from the prior year.
- Income from Continuing Operations fell to 37000000.0 in Q1 2026 per BDX's latest filing, from 382000000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 574000000.0 in Q2 2025 and bottomed at 37000000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 363294117.65 across 5 years, with a median of 390000000.0 in 2022.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations surged 161.44% — and 2026, when it tumbled 123.42%.
- Becton Dickinson's Income from Continuing Operations stood at 509000000.0 in 2022, then sank by 44.6% to 282000000.0 in 2023, then grew by 7.45% to 303000000.0 in 2024, then rose by 26.07% to 382000000.0 in 2025, then slumped by 109.69% to 37000000.0 in 2026.
- Business Quant data shows BDX's Income from Continuing Operations at 37000000.0 in Q1 2026, 382000000.0 in Q4 2025, and 493000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 108.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 452.00 Mn |
| Mar 31, 2026 | -37.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 493.00 Mn |
| Jun 30, 2025 | 574.00 Mn |
| Mar 31, 2025 | 158.00 Mn |
| Dec 31, 2024 | 303.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 487.00 Mn |
| Mar 31, 2024 | 537.00 Mn |
| Dec 31, 2023 | 282.00 Mn |
| Sep 30, 2023 | 153.00 Mn |
| Jun 30, 2023 | 407.00 Mn |
| Mar 31, 2023 | 461.00 Mn |
| Dec 31, 2022 | 509.00 Mn |
| Sep 30, 2022 | 287.00 Mn |
| Jun 30, 2022 | 390.00 Mn |
| Mar 31, 2022 | 390.00 Mn |
| Dec 31, 2021 | 568.00 Mn |
| Sep 30, 2021 | 155.00 Mn |